Supplementary Tables 3, 7-8 from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
Harinad B. Maganti(University of Ottawa), William L. Stanford(University of Ottawa), Adrian T. Grzybowski, Safwat T. Khan(University of Toronto), Julien Yockell‐Lelièvre(Esri (Canada)), Joel P. Howard(Institute for Stem Cell Biology and Regenerative Medicine), Elham Sabri(Ottawa Hospital), Janet L. Manias Rothberg(University of Ottawa), Mitchell Sabloff(University of Ottawa), Christopher Cafariello(University of Ottawa), Alexander J. Ruthenburg(University of Chicago), Christopher J. Porter(Ottawa Hospital), F. Jeffrey Dilworth(University of Ottawa), Hani Jrade(University of Ottawa), Caryn Y. Ito(University of Ottawa), Hannah L. Battaion(University of Ottawa), Yuefeng Li(University of Ottawa), Theodore J. Perkins(Ottawa Hospital)
Cited by 0
Related Papers
Age of Transfused Blood in Critically Ill Adults
|New England Journal of Medicine|2015|559
Concise Review: Stem Cell Antigen-1: Expression, Function, and Enigma
|Stem Cells|2007|407